M. A. von der Möhlen

Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.

T. van der Poll, J. T. ten Cate, S. Deventer, 1993, The Journal of infectious diseases.

Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study.

H. Büller, J. T. ten Cate, E. Van Beek, 1994, The Netherlands journal of medicine.

Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor.

T. van der Poll, S. V. van Deventer, M. Levi, 1996, Journal of immunology.

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.

A. Eerenberg, N. Friedmann, N. Wedel, 1995, The Journal of infectious diseases.

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.

C. Sprung, J. T. ten Cate, S. V. van Deventer, 1992, The Journal of infectious diseases.

Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23).

J. T. ten Cate, S. V. van Deventer, M. Levi, 1995, Blood.

Recombinant endotoxin-binding protein (rBPI23) attenuates endotoxin-induced circulatory changes in humans.

R. D. de Winter, S. V. van Deventer, N. Friedmann, 1995, Journal of inflammation.